Preventing invasive candida infections. Where could we do better?

Area of Science:

• Infectious Diseases
• Critical Care Medicine
• Mycology

Background:

• Invasive candidiasis presents high mortality rates (35-60%), comparable to septic shock.
• Epidemiology and pathogenesis vary with immune status; immunocompromised patients often develop candidaemia, while critically ill patients are more prone to non-candidaemic systemic candidiasis.
• Distinguishing colonization from proven invasive candidiasis in critically ill patients is difficult, with a 7-10 day progression period.

Purpose of the Study:

• To review the challenges in diagnosing non-candidaemic systemic candidiasis in critically ill patients.
• To evaluate the role of risk assessment strategies in guiding antifungal prophylaxis and empirical treatment.
• To highlight the clinical utility of strategies like colonization index and candida score.

Main Methods:

• Review of epidemiological and clinical data on invasive candidiasis.
• Analysis of diagnostic challenges in differentiating colonization from infection.
• Evaluation of existing risk assessment strategies for empirical antifungal therapy.

Main Results:

• Non-candidaemic systemic candidiasis is difficult to diagnose in critically ill patients, despite high colonization rates (up to 80%).
• Risk assessment strategies, including colonization index and candida score, are widely used despite limited evidence.
• These strategies have shown effectiveness in reducing the incidence of invasive candidiasis.

Conclusions:

• Accurate differentiation between colonization and invasive candidiasis is crucial for effective patient management.
• Risk assessment tools, though imperfect, are valuable for initiating timely antifungal interventions in high-risk critically ill patients.
• Further research is needed to refine diagnostic and therapeutic approaches for invasive candidiasis in critical care settings.